Dhingra Ankur
SEC CIK 1849682 · EDGAR
BoughtSold
Most active insiders at ILMN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meister Keith A. | Dir | — | $591.13M |
| 2 | Davies Scott M | CLO | — | $531.3K |
| 3 | Leckman Patricia | SVP, CHRO | — | $529.7K |
| 4 | Wedel Christensen Jakob | SVP, Strategy, Corp Development | — | $366.1K |
| 5 | Ericksen Scott D | VP, CAO | — | $305.1K |
| 6 | Gottlieb Scott | Dir | $84.6K | — |
| 7 | Sullivan Michael C | Chief Commercial Off | — | — |
| 8 | Barnard Steven | SVP, CTO | — | — |
| 9 | Pegels Kevin Carl | Chief of Gbl Ops | — | — |
| 10 | Dhingra Ankur | SVP, CFO | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-09 | 2026-03-05 | ILMN | ILLUMINA, INC. | Dhingra Ankur | SVP, CFO | A - Grant | $128.24 | +9,358 | 34.3K | +38% | +$1.20M |
| 2025-05-14 | 2025-05-12 | ILMN | ILLUMINA, INC. | Dhingra Ankur | SVP, CFO | P - Purchase | $81.21 | +6,100 | 24.9K | +32% | +$495.4K | |
| D | 2025-03-07 | 2025-03-05 | ILMN | ILLUMINA, INC. | Dhingra Ankur | SVP, CFO | A - Grant | $0.00 | +9,803 | 18.8K | +109% | $0 |
| D | 2024-05-08 | 2024-05-06 | ILMN | ILLUMINA, INC. | Dhingra Ankur | SVP, CFO | A - Grant | $0.00 | +8,826 | 8,826 | New | $0 |
| I | 2024-03-27 | 2024-03-26 | SMMT | Summit Therapeutics Inc. | Dhingra Ankur | CFO | P - Purchase | $3.75 | +100.0K | 355.0K | +39% | +$375.0K |
| MI | 2023-12-13 | 2023-12-13 | SMMT | Summit Therapeutics Inc. | Dhingra Ankur | CFO | P - Purchase | $2.17 | +20.4K | 255.0K | +9% | +$44.3K |
| AI | 2023-03-08 | 2022-08-16 | SMMT | Summit Therapeutics Inc. | Dhingra Ankur | CFO | P - Purchase | $0.97 | +24.7K | 38.2K | +182% | +$23.9K |
| A | 2023-03-08 | 2022-08-16 | SMMT | Summit Therapeutics Inc. | Dhingra Ankur | CFO | P - Purchase | $0.97 | +13.0K | 39.5K | +49% | +$12.6K |
| I | 2023-03-08 | 2023-03-07 | SMMT | Summit Therapeutics Inc. | Dhingra Ankur | CFO | P - Purchase | $1.05 | +196.4K | 234.6K | +514% | +$206.2K |
| I | 2022-08-17 | 2022-08-16 | SMMT | Summit Therapeutics Inc. | Dhingra Ankur | CFO | P - Purchase | $0.97 | +24.7K | 38.2K | +182% | +$23.9K |
| 2022-08-17 | 2022-08-16 | SMMT | Summit Therapeutics Inc. | Dhingra Ankur | CFO | P - Purchase | $0.97 | +11.6K | 38.1K | +44% | +$11.2K | |
| 2022-03-28 | 2022-03-25 | CDNA | CareDx, Inc. | Dhingra Ankur | CFO | F - Tax | $37.90 | -1,254 | 33.1K | -4% | -$47.5K | |
| D | 2022-02-04 | 2022-02-02 | CDNA | CareDx, Inc. | Dhingra Ankur | CFO | A - Grant | $0.00 | +19.9K | 34.4K | +137% | $0 |
| I | 2021-11-29 | 2021-11-24 | CDNA | CareDx, Inc. | Dhingra Ankur | CFO | P - Purchase | $42.34 | +5,000 | 5,000 | New | +$211.7K |
Purchase Sale Sale after option exercise All abbreviations